Sonoma Pharmaceuticals SNOA
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2024Q4 | 2.69 | 5 | -18.16 | -1 | -6.79 | 14 |
| 2024Q3 | 3.07 | 5 | -11.81 | -1 | -4.46 | 14 |
| 2024Q2 | 4.24 | 5 | -20.57 | -1 | -8.05 | 14 |
| 2024Q1 | 3.33 | 6 | -16.63 | -1 | -7.27 | 15 |
| 2023Q4 | 3.61 | 7 | -14.01 | -1 | -6.13 | 15 |
| 2023Q3 | 15.44 | 6 | -22.98 | -1 | -10.05 | 14 |
| 2023Q2 | 21.40 | 7 | -18.63 | -1 | -8.83 | 16 |
| 2023Q1 | 19.53 | 8 | -19.33 | -1 | -8.67 | 16 |
| 2022Q4 | 22.40 | 6 | -30.83 | -2 | -13.42 | 14 |
| 2022Q3 | 42.60 | 7 | -13.58 | -1 | -6.33 | 15 |
| 2022Q2 | 58.40 | 8 | -10.65 | -1 | -4.93 | 17 |
| 2022Q1 | 80.20 | 9 | -29.64 | -3 | -15.42 | 19 |
| 2021Q4 | 91.20 | 11 | -8.34 | -1 | -4.82 | 19 |
| 2021Q3 | 111.60 | 11 | -1.24 | 0 | -0.59 | 20 |
| 2021Q2 | 146.80 | 5 | -22.00 | -1 | -7.54 | 14 |
| 2021Q1 | 148.60 | 5 | -41.41 | -4 | -22.04 | 15 |
| 2020Q4 | 145.20 | 12 | -5.44 | -1 | -3.57 | 18 |
| 2020Q3 | 167.40 | 12 | 1.08 | 0 | 0.66 | 18 |
| 2020Q2 | 142.40 | 11 | 2.48 | 0 | 1.47 | 18 |
| 2020Q1 | 98.00 | 9 | -13.80 | -1 | -8.85 | 15 |